Bank of New York Mellon »

Viking Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $29M 349k 82.00
2023-12-31 $6.3M 338k 18.61
2023-09-30 $3.7M 330k 11.07
2023-06-30 $5.5M 338k 16.21
2023-03-31 $2.4M 142k 16.65
2022-12-31 $1.5M 158k 9.40
2022-09-30 $284k 104k 2.73
2022-06-30 $305k 106k 2.88
2022-03-31 $976k 326k 3.00
2021-12-31 $1.1M 258k 4.35
2021-09-30 $1.7M 266k 6.28
2021-06-30 $1.5M 250k 5.99
2021-03-31 $1.9M 299k 6.33
2020-12-31 $1.7M 300k 5.63
2020-09-30 $1.8M 312k 5.82
2020-06-30 $2.3M 315k 7.21
2020-03-31 $1.5M 315k 4.68
2019-12-31 $2.5M 311k 8.02
2019-09-30 $2.0M 286k 6.88
2019-06-30 $3.1M 369k 8.30
2019-03-31 $3.2M 320k 9.94
2018-12-31 $3.0M 387k 7.65
2018-09-30 $6.7M 386k 17.41
2018-06-30 $3.3M 346k 9.48
2018-03-31 $109k 25k 4.31